14.70
Rallybio Corp Borsa (RLYB) Ultime notizie
Rallybio Corporation Q1 2026 Earnings: Wider Loss Reflects R&D Investment, Stock GainsBuyback Announcement Report - Newser
RLYB Stock Chart | RALLYBIO CORP (NASDAQ:RLYB) - ChartMill
Adar1 Capital Management, Daniel Schneeberger buy $226k Rallybio stock By Investing.com - Investing.com Nigeria
Can Rallybio Corporation (RLYB) Sustain Its +0.65% Momentum This Week? 2026-05-21Open Signal Network - Newser
Adar1 Capital Management, Daniel Schneeberger buy $226k Rallybio stock - Investing.com India
ADAR1-managed funds boost Rallybio (RLYB) stake with open-market share buys - Stock Titan
Rallybio Corporation (RLYB) Q1 2026 Earnings Miss by Significant: Key TakeawaysEPS Growth Rate - Newser
Rallybio Stock (RLYB) Opinions on Merger Termination Fee and Insider Buys - Quiver Quantitative
Insider Stock Purchases: May 16, 2026 - Quiver Quantitative
Adar1 Capital Management buys $1.11m of Rallybio (RLYB) stock By Investing.com - Investing.com South Africa
Why Rallybio Corporation (RLYB) Just Surged +0.63% — Key Levels Ahead 2026-05-15Open Stock Signal Network - newser.com
Adar1 Capital Management buys $1.11m of Rallybio (RLYB) stock - Investing.com
ADAR1 funds boost Rallybio (RLYB) stake with May open-market buys - Stock Titan
Viking Global Group (RLYB) discloses 528,954 shares, 9.99% stake - Stock Titan
Nantahala and principals report 300,635 RallyBio shares (RLYB) - Stock Titan
Cormorant (RLYB) reports 400,000 shares (7.56%) held by fund - Stock Titan
Balyasny group discloses 376,573 Rallybio shares (NASDAQ: RLYB) - Stock Titan
What's Driving Rallybio's Recent Surge and Investor Interest - Kavout
Adar1 capital, manager Daniel Schneeberger buy $711,054 Rallybio stock. By Investing.com - Investing.com Nigeria
Adar1 capital, manager Daniel Schneeberger buy $711,054 Rallybio stock. - Investing.com
Rallybio (RLYB) insider funds add 50,800 shares in open-market buys - Stock Titan
Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Rallybio (NASDAQ: RLYB) trims Q1 loss, set to receive $50M termination fee - Stock Titan
Adar1 Capital, Daniel Schneeberger buy $2.18m Rallybio stock By Investing.com - Investing.com Nigeria
Adar1 Capital, Daniel Schneeberger buy $2.18m Rallybio stock - Investing.com
ADAR1-managed funds boost Rallybio Corp (RLYB) stake with open-market buys - Stock Titan
Rallybio (RLYB) gets new 10% insider filing from ADAR1 group - Stock Titan
5AM Ventures group reports 0% Rallybio (RLYB) ownership after May 4 share sales - Stock Titan
Rallybio(RLYB) Stock Options Chain | Quotes & News - Moomoo
[RW] Rallybio Corp SEC Filing - Stock Titan
Rallybio stock surges after receiving $50M termination fee By Investing.com - Investing.com South Africa
Rallybio stock surges after receiving $50M termination fee - Investing.com
Rallybio merger scrapped; New Haven biotech to receive $50M breakup fee - Hartford Business Journal
Rallybio Corporation Files Form 8-K with SEC Detailing Waiver Agreement and Entity Information - Minichart
RLYB Stock Under Pressure As Merger Scrutiny Mounts - timothysykes.com
Rallybio Receives Termination Fee After Candid Deal Collapse - TipRanks
Rallybio, Candid and UCB Sign Waiver; $50 Million Fee Follows Merger Termination - TradingView
Rallybio CorpCandid terminates merger agreement with Rallybio on May 3, 2026SEC filing - marketscreener.com
Rallybio (RLYB) to receive $50,000,000 after Candid chooses UCB deal - Stock Titan
Candid Therapeutics, Inc. cancelled the acquisition of Rallybio Corporation in a reverse merger transaction. - marketscreener.com
Laurion Capital (RLYB) discloses 302,756 shares, 5.72% stake - Stock Titan
RLYB - Finviz
RLYB Technical Analysis | Trend, Signals & Chart Patterns | RALLYBIO CORP (NASDAQ:RLYB) - ChartMill
[S-4/A] Rallybio Corp Amended Business Combination Registration | RLYB SEC FilingForm S-4/A - Stock Titan
Rallybio Corporation (RLYB) Sector Rotation | Rallybio Corporation notches 13.9% EPS beat on narrower lossCommunity Buy Signals - Xã Vĩnh Công
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):